MRI findings in fragile X-associated tremor/ataxia syndrome

  • Thomas ClaeysEmail author
  • Alexandra Boogers
  • Dieter Vanneste



The authors would like to acknowledge Wim Vandenberghe, M.D. Ph.D, movement disorders specialist at University Hospitals Leuven, for discussion and review of this manuscript.

Compliance with ethical standards

Conflicts of interest

The authors report no disclosures relevant to the manuscript.

Ethical approval

Approval from the institutional review board was not required for this study.

Informed consent

For this case report, oral consent by the patient was acquired.


  1. 1.
    Hall DA, O’keefe JA (2012) Fragile X-associated tremor ataxia syndrome: the expanding clinical picture, pathophysiology, epidemiology, and update on treatment. Tremor Other Hyperkinet Mov (N Y) 2:2–11Google Scholar
  2. 2.
    Hagerman R, Hagerman P (2013) Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol 12:786–798CrossRefGoogle Scholar
  3. 3.
    Muzar Z, Lozano R (2014) Current research, diagnosis, and treatment of fragile X-associated tremor/ataxia syndrome. Intractable Rare Dis Res 3(4):101–109CrossRefGoogle Scholar
  4. 4.
    Brunberg JA, Jacquemont S, Hagerman RJ et al (2002) Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. Am J Neuroradiol 23:1757–1766PubMedGoogle Scholar
  5. 5.
    Apartis E, Blancher A, Meissner W et al (2012) FXTAS: new insights and the need for revised diagnostic criteria. Neurology 79:1898–1907CrossRefGoogle Scholar

Copyright information

© Belgian Neurological Society 2019

Authors and Affiliations

  1. 1.Department of NeurologyUniversity Hospitals LeuvenLeuvenBelgium
  2. 2.Department of RadiologyUniversity Hospitals LeuvenLeuvenBelgium

Personalised recommendations